BerandaALKS • NASDAQ
add
Alkermes Plc
Tutup sebelumnya
$28,42
Rentang hari
$27,90 - $28,46
Rentang tahun
$22,90 - $32,88
Kapitalisasi pasar
4,54Â M USD
Volume Rata-Rata
1,51Â jt
Rasio P/E
14,32
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 378,14Â jt | -0,73% |
Biaya operasional | 210,29Â jt | -8,67% |
Laba bersih | 92,38Â jt | 93,44% |
Margin laba bersih | 24,43 | 94,82% |
Penghasilan per saham | 0,73 | 14,06% |
EBITDA | 111,73Â jt | 3,59% |
Tarif pajak efektif | 15,82% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 908,86Â jt | 2,22% |
Total aset | 2,16Â M | -5,44% |
Total liabilitas | 863,18Â jt | -6,55% |
Total ekuitas | 1,29 M | — |
Saham yang beredar | 161,80 jt | — |
Harga terhadap nilai buku | 3,56 | — |
Tingkat pengembalian aset | 12,01% | — |
Tingkat pengembalian modal | 15,82% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 92,38Â jt | 93,44% |
Kas dari operasi | 81,59Â jt | -18,17% |
Kas dari investasi | -109,33Â jt | 8,40% |
Kas dari pembiayaan | -111,11Â jt | -7.190,87% |
Perubahan kas bersih | -138,86Â jt | -667,84% |
Arus kas bebas | 31,74Â jt | -63,37% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
2.100
